MOSCOW, February 23 – RIA Novosti. The Russian Direct Investment Fund (RDIF) has confirmed the registration of the Sputnik V COVID-19 vaccine in Kyrgyzstan, noting that this country has become the fourth country in Central Asia to register this Russian drug.
Earlier on Tuesday, the press service of the Ministry of Health of Kyrgyzstan, RIA Novosti reported that the Sputnik V vaccine is officially registered in the country.
“Kyrgyzstan has become the fourth state in Central Asia where the Sputnik V vaccine is registered. The supply of the drug will make a significant contribution to ensuring the safety of health of the country's residents and preventing coronavirus infection,” the head of the fund, Kirill Dmitriev, said in a statement from the RDIF.
“Sputnik V” is one of the three world vaccines against coronavirus in terms of the number of approvals received by state regulators, the fund said.